ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.
ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.
复制标题
DOI:
10.1126/science.1217697
复制
发表时间:
2012-03-23
期刊:
影响因子:
--
通讯作者:
Landreth GE
中科院分区:
文献类型:
--
作者:
Cramer PE;Cirrito JR;Wesson DW;Lee CY;Karlo JC;Zinn AE;Casali BT;Restivo JL;Goebel WD;James MJ;Brunden KR;Wilson DA;Landreth GE
Alzheimer’s disease (AD) is associated with impaired clearance of β-amyloid (Aβ) from the brain, a process normally facilitated by apolipoprotein E (apoE). ApoE expression is transcriptionally induced through the action of the nuclear receptors peroxisome proliferator–activated receptor gamma and liver X receptors in coordination with retinoid X receptors (RXRs). Oral administration of the RXR agonist bexarotene to a mouse model of AD resulted in enhanced clearance of soluble Aβ within hours in an apoE-dependent manner. Aβ plaque area was reduced more than 50% within just 72 hours. Furthermore, bexarotene stimulated the rapid reversal of cognitive, social, and olfactory deficits and improved neural circuit function. Thus, RXR activation stimulates physiological Aβ clearance mechanisms, resulting in the rapid reversal of a broad range of Aβ-induced deficits.
登录
查看更多内容
影响因子:
2.7
作者:
Wesson, Daniel W.;Wilson, Donald A.
通讯作者:
Wilson, Donald A.
DOI:
10.1523/jneurosci.2085-11.2011
发表时间:
2011-11-02
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Wesson DW;Borkowski AH;Landreth GE;Nixon RA;Levy E;Wilson DA
通讯作者:
Wilson DA
影响因子:
25
作者:
Palop, Jorge J.;Mucke, Lennart
通讯作者:
Mucke, Lennart
影响因子:
5.3
作者:
Comery, TA;Martone, RL;Marquis, KL
通讯作者:
Marquis, KL
DOI:
10.1146/annurev-pathol-011110-130138
发表时间:
2011
期刊:
Annual review of pathology
影响因子:
--
作者:
Odegaard JI;Chawla A
通讯作者:
Chawla A